1) Thanks again for bringing this to our attention, as I have...

1) Thanks again for bringing this to our attention, as I have said in the past, it pays to keep tabs on the competition. It will be for the betterment of all of us. There is nothing in the world that is infallible. This is the very reason that even I being so confident with our beaut company and product, will never back ONLY the one horse. Spread, diversify...and not just in one asset class, right?

Listen to what others are saying, even if they are negative on it or have Cons...we may learn from it or at least research more to get an even more informed opinion based on facts.



2) Getting back on the topic of this thread...
Ampio employ articular injections, there are disadvantages to this (and thanks to a mate for highlighting this out).

• It can lead to a chance of infection
• It can be painful to administer
• It's joint specific

3) More than anything, read this, it will put your mind at ease if you are wary:

https://www.********/investing/2021/08/05/heres-why-ampio-pharmaceuticals-stock-is-surging-t/

In case the above link gets edited, here is a screenshot:





One line from the above link says a lot, my emphasis in red:



"The company is still attempting to develop Ampion as an under-the-kneecap injection for osteoarthritis pain despite multiple clinical trial failures, and a stinging rejection from the FDA a few years ago".

"Ampion isn't an innovative new biologic drug; it's just albumin, the most abundant protein found circulating in the plasma of healthy people. If you've ever given blood, your albumin was most likely separated from your plasma and used as replacement therapy by patients who can't produce enough of their own. For everyone else, though, its utility is highly questionable."


DYOR